
Join to View Full Profile
1441 Eastlake AveLos Angeles, CA 90033
Dr. Ali is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sana Ali is an oncology specialist based in Los Angeles, CA, currently serving as a Hematology Oncology Fellow at the University of Southern California. She completed her fellowship in Hematology and Medical Oncology at USC/LA General and her residency in Internal Medicine at Los Angeles County-Harbor-UCLA Medical Center. Dr. Ali graduated from Chicago Medical School at Rosalind Franklin University in 2020. Her recent publications focus on topics such as ALK inhibitors in cancer, real-world incidence of ALK alterations in non-small cell lung cancer, and improving oncology patient care processes.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Fellowship, Hematology and Medical Oncology, 2023 - 2026
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 2020 - 2023
- Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2020
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Real-World Incidence of Anaplastic Lymphoma Kinase Alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles.Darin Poei, Sana Ali, Jacob S Thomas, Jorge J Nieva, Robert C Hsu
Cancer Research Communications. 2025-02-01 - Advances in adoptive cell therapies in small cell lung cancer.Eljie Isaak Bragasin, Justin Cheng, Lauren Ford, Darin Poei, Sana Ali
Exploration of Targeted Anti-Tumor Therapy. 2025-01-01 - 12 citationsALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategies.Darin Poei, Sana Ali, Shirley Ye, Robert Hsu
Cancer Drug Resistance. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: